Blood plasma donations for manufacture of medicines under way after ban lifted

PA Reporters
·4-min read

Donations of blood plasma in England for use in the manufacture of medicines have begun after the lifting of a ban which lasted for more than two decades.

Volunteers can donate at 14 centres across the country from Wednesday, and the service will run initially for three months.

The donations will be used to make antibody-based medicines, called immunoglobulins, for people with rare immune diseases.

It comes after the Government lifted a ban in February which was imposed on UK donors in 1998 amid concerns about the spread of a human variant of bovine spongiform encephalopathy (BSE), known as Creutzfeldt-Jakob disease (CJD).

Martin Rengger, 51, was the first person to donate at the Twickenham hub in west London on Wednesday morning and described the process as “so easy”.

He told the PA news agency: “It was absolutely fine, I’ve donated plasma before so I kind of knew what I was expecting, there was nothing different than it was in the Covid plasma times.”

Mr Rengger went on: “I had Covid at Christmas and was fine with it, but I started giving plasma from that and just got asked if I would continue giving plasma and I just think if I can’t spare an hour a month coming down here doing this then I think there’s something wrong.

Mr Rengger with his bag of plasma
Martin Rengger with his bag of plasma (Jonathan Brady/PA)

“I think it’s nice to be able to do something and hopefully help somebody that needs it.”

He added: “It makes you feel good. It’s not painful, it’s not uncomfortable, it’s so easy.”

NHS Blood and Transplant (NHSBT) said that around 17,000 people needed immunoglobin therapy in 2018/19 for a range of diseases and genetic disorders.

These included immune disorders such as common variable immune deficiency (CVID) and neurological disorders like Guillain–Barre syndrome and myasthenia gravis.

To view this content, you'll need to update your privacy settings.
Please click here to do so.

The medicines are also used to help treat cytopenia, a disorder featuring a low mature red blood cell count which can occur following radiotherapy and chemotherapy for cancer treatment, as well as dermatological disorders like Kawasaki syndrome and toxic epidermal necrolysis.

Amid a global supply shortage due to rising demand, the UK has previously depended on imports of blood plasma from other countries – mainly the US.

Dr Gail Miflin, chief medical officer for NHSBT, said: “Plasma is made into life-saving medicines for people with rare diseases.

“There is a growing need for plasma for medicines and a worldwide shortage of donors.”

She said that a “dedicated plasmapheresis programme” would “greatly increase NHSBT’s ability to provide plasma at volume” and reduce the reliance on plasma from overseas.

Natalie Beeton, 26, from Borehamwood, Hertfordshire, relies on immunoglobulin medicines to protect against serious illness due to her immunodeficiency.

Natalie Beeton
Natalie Beeton relies on immunoglobulin medicines to protect against serious illness due to her immunodeficiency (NHS Blood and Transplant/PA)

Doctors believe her immune system was damaged by glandular fever and she has been receiving an antibody transfusion every six weeks at London’s Royal Free Hospital since July 2019.

“It pretty much killed my immune system,” she said.

Ms Beeton, an underwriter for a financial company, is going through tests for CVID.

She added: “I was at constant risk of serious infections because my immune system could not stop anything.

“My illness is long-term and I am going to need this medicine for the rest of my life. Donations are the juice that keeps me going.”

Donations will be taken at repurposed former convalescent centres originally created for coronavirus research.

They are in Stockton, Barnsley, Manchester, Bolton, Birmingham, Coventry, Wolverhampton, Chelmsford, Reading, Bristol, Croydon, Stratford, Tottenham and Twickenham.

More than 1,500 people, drawn from an existing blood donor base, are booked in to donate in the first week, with open recruitment to be introduced in the future.

Sue Dimmock, acting chairwoman of UK Primary Immune-deficiency Patient Support (UKPIPS), said: “Those of us who are unable to make our own antibodies completely rely on regular infusions of donated, plasma-derived antibodies (immunoglobulin) to fight infection and to stay as healthy as possible.

“Without this treatment, we have an extremely limited defence against infection and disease.”

Minister for innovation Lord Bethell hailed the “historic occasion” and urged people thinking about donating plasma to “absolutely take the plunge”.